COMMUNIQUÉS West-GlobeNewswire

Wellness Matrix Group To Initiate State-of-the-Art Wellness Model Program
17/01/2019
LOS ANGELES, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. (OTC:WMGR) announces today that it will shortly introduce what it considers the world's most technologically advanced health care models in [...]
Progressive Care Releases Open Letter to Shareholders
17/01/2019
Open Letter to Shareholders Summarizes Recent Milestones MIAMI, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its PharmCo subsidiaries, is a South Florida health services organization and [...]
Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call
17/01/2019
JERSEY, Channel Islands, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, [...]
Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President
17/01/2019
TORONTO, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) today announced that Narbe Alexandrian has been appointed as President of the Company, effective [...]
American Postal Workers Union Health Plan Selects Inovalon ONE® Platform
17/01/2019
Partnership Focuses on Leveraging Advanced Analytics and Technologies to Improve Quality and Financial Performance BOWIE, Md. , Jan. 17, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company [...]
Ossur Hf : Q4&FY 2018 Results - Conference call Tuesday 5 February at 9:00 CET
17/01/2019
Announcement no. 03/2018 17 January 2019 Conference call on Tuesday 5 February at 9:00 CET / 8:00 GMT / 3:00 EDT Össur will publish its financial results for Q4&FY 2018 prior to market opening on Tuesday 5 February [...]
ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
17/01/2019
Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]
Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board
17/01/2019
Dr. Abbruzzese to add significant pancreatic cancer expertise to advance drug development HOUSTON, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical [...]
Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes
17/01/2019
THE WOODLANDS, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug Administration’s [...]
First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients
17/01/2019
DARTMOUTH, Nova Scotia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that the first patient has been treated in the Phase 1 trial [...]
HEXO to begin trading on the NYSE American
17/01/2019
GATINEAU, Quebec, Jan. 17, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO ) is pleased to announce that its common shares have been approved for listing on the NYSE American LLC ("NYSE American [...]
Début des négociations des actions d’HEXO au NYSE American
17/01/2019
GATINEAU, Québec, 17 janv. 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO ) a le plaisir d’annoncer que l’inscription de ses actions ordinaires au NYSE American LLC (« NYSE American ») a été [...]
AVROBIO, Inc. Announces Analyst and Investor Event and Upcoming Clinical Data Presentations at WORLDSymposium 2019
17/01/2019
Analyst and Investor Event to be Webcast on Wednesday, February 6, 2019 at 6:30 p.m. ET CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene [...]
Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061
17/01/2019
Data for the 1.8 mg dose demonstrated meaningfully greater efficacy than the 0.9 mg dose Cohort 2 data showed statistically and clinically significant 1.1% reduction of A1C at the 1.8 mg dose relative to placebo [...]
ContraFect Announces Additional $2.3 Million in Funding from CARB-X to Support Gram-Negative Lysin Program
17/01/2019
YONKERS, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Avivagen Announces CEO Letter to Shareholders
17/01/2019
OTTAWA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce its 2019 letter to shareholders by Chairman and interim CEO Kym Anthony. To our shareholders: As the consumer, [...]
Interim report September 1, 2018 – November 30, 2018
17/01/2019
Company announcement no.01/2019 Report attached For further information, please contact: Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50 Camilla Lercke, Head of Media Relations, Tel: +45 53 39 23 84 About [...]
PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium
17/01/2019
Stockholm, January 17, 2019. PledPharma AB (publ) announces that the company’s global phase III program, POLAR, has been accepted for a poster presentation during the Gastrointestinal (GI) Cancers Symposium in January [...]
Nicox : Point d'activité et résumé financier du quatrième trimestre 2018
17/01/2019
Communiqué de presse Nicox : Point d'activité et résumé financier du quatrième trimestre 2018 ................................................. Augmentation de 47% du nombre total de prescriptions de VYZULTA ® pour le [...]

Pages